What is it about?
Octreotide and pasireotide exert similar effects on cells from the main types of human pituitary tumors, with no overt correspondence between in vitro effects and somatostatin receptor tumor profile.
Featured Image
Read the Original
This page is a summary of: Octreotide and pasireotide (dis)similarly inhibit pituitary tumor cellsin vitro, Journal of Endocrinology, September 2016, Bioscientifica,
DOI: 10.1530/joe-16-0332.
You can read the full text:
Contributors
The following have contributed to this page
